SCHEMBL25461997

SCHEMBL25461997

c1cnc2c(-c3cc4c(cn3)sc3ccccc34)nccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.38
KDM4E B2RXH2 4/20 0.38
MAPT P10636 4/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ESR1 P03372 1/20 0.38
POLB P06746 1/20 0.38
AGTR1 P30556 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
GABRA1 P14867 2/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25462011 0.90 KDM4E (0.38) LMNAKDM4EMAPTALDH1A1MEN1
SCHEMBL25461713 0.87 GABRA1 (0.40) KDM4EMAPTALDH1A1KMT2AGABRA1
SCHEMBL25461835 0.85 HTR2C (0.37) LMNAKDM4EMAPTALDH1A1MEN1
SCHEMBL25461714 0.83 LMNA (0.41) LMNAKDM4EMAPTALDH1A1MEN1
SCHEMBL25461994 0.82 GABRA1 (0.39) LMNAKDM4EMAPTALDH1A1GABRA1
SCHEMBL25462007 0.81 GABRA1 (0.38) KDM4EMAPTALDH1A1KMT2APOLB
SCHEMBL25461992 0.80 GABRA1 (0.38) LMNAKDM4EMAPTALDH1A1POLB
SCHEMBL25462063 0.79 LMNA (0.39) LMNAKDM4EMAPTALDH1A1MEN1
SCHEMBL25461979 0.77 NPC1 (0.40) LMNAKDM4EMAPTALDH1A1POLB
SCHEMBL25461989 0.77 NPC1 (0.54) KDM4EALDH1A1MEN1KMT2AGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 LMNA 1600/4885KDM4E 2555/4885MAPT 2164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.